Tanker Investments (TIL) Peer Comparison

$7.61

$0.03 (0.40%)

As on 31-Aug-2026 16:00EDT

Market cap

$51 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Edit

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	51	16,765	16,261	13,492	11,994
Revenue ($ Mln)	--	2,782	1,054	2,436	670
Net Profit ($ Mln)	-30.28	491.50	755.85	860.62	-319.95
Net Margin (%)	--	17.67	71.69	35.33	-47.79
RoE (%)	-27.37	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	0.49	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.00	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	0.04	1,982.07	103.47	85.67	19.14
Gross Profit	-0.53	760.62	588.53	2,236.43	829.45
Operating Expenses	36.15	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-36.18	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-30.28	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-30.28	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	107.38	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	87.03	187.89	384.48	288.55	1,362.63
Current Liabilities	3.31	1,435.43	464.70	361.93	283.35
Total Liabilities	203.52	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	126.11	1,006.90	895.24	1,243.41	440.60
Current Assets	71.61	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	203.52	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	3.67	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-36.62	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	25.48	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	7.29	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-31.35	53.56	-30.01	32.82	-0.17
ROE (%)	-27.37	110.09	163.18	42.98	-71.14
ROA (%)	-11.78	15.64	26.53	29.32	-16.12
EBIT Margin (%)	--	21.13	5.73	31.04	-0.77
Net Margin (%)	--	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	--	0.00	0.00	0.00	0.00

Growth Ratios

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	--	24.67	114.85	9.23	12.22
EBIT Growth (%)	71.50	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	64.17	17.50	378.76	42.89	-115.58
EPS Growth (%)	65.39	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-20.67	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-1.05	36.06	-59.76	15.79	-2,869.63
Price / Book Value	0.66	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-1.29	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.00	0.05	0.00	0.09
Current Ratio	21.67	0.73	2.99	3.46	5.90
Quick Ratio	21.67	0.73	2.32	3.38	5.90
Interest Coverage	-4.51	--	1.62	--	-1.72

Operating Efficiency Ratios

	Tanker Investments (TIL)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	--	15.88	21.25	13.74	1.28
Asset Turnover	0.00	0.89	0.37	0.83	0.34
Receivable days	--	50.42	85.52	43.48	1.50
Inventory Days	--	--	1,056.70	96.17	--
Payable days	491.79	6.26	331.01	147.97	221.81
Cash Conversion Cycle	--	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly